Prevalence and diagnosis of congenital uterine anomalies in women with reproductive failure: a critical appraisal.
By Sotirios H. Saravelos, K. Cocksedge, T. Li. Human Reproduction Update, 2008
645 citations recorded by the source corpus.
Subfields: Immunology, Obstetrics and Gynecology, Public Health, Environmental and Occupational Health
View Paper: https://www.semanticscholar.org/paper/b6797ac239a52d3c545eef62178d79113f90205a
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Immunology
In Obstetrics and Gynecology
Citations in the corpus
- ESHRE guideline: recurrent pregnancy loss (2018, methodology): “Conditional ⊕⊕○○ MRI is not recommended as first line option for the assessment of uterine malformations in women with RPL, but can be used where 3D ultrasound (3D US) is not available (Oppelt et al., 2007; Saravelos et al., 2008; Chan et al., 2011b).”
- The prevalence of congenital uterine anomalies in unselected and high-risk populations: a systematic review (2011, methodology): “We also consider our classification of which tests offer an optimal diagnosis and differentiation of uterine anomalies is more robust and relevant than the one used by Saravelos et al. (2008).”
- The ESHRE/ESGE consensus on the classification of female genital tract congenital anomalies, (2013, positive): “They represent a rather common benign condition with a prevalence of 4–7% (Grimbizis et al., 2001; Saravelos et al., 2008; Chan et al., 2011a).”